Published in
Elsevier, Annals of Oncology, (31), p. S440, 2020
DOI: 10.1016/j.annonc.2020.08.580
Links
Tools
Efficacy and safety of anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer - A single-arm, multi-center, phase II study (ALTER-C-002 trial)
Journal article published in 2020 by
K. Ding,
Y. Liu,
J. Chen,
J. Ying,
Q. Xu,
D. Xu,
L. Sun,
Y. Yuan
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 